SC

Shaan C. Gandhi

VP at Pfizer

Cambridge, Massachusetts

Overview

Work Experience

P

Pfizer

  • Vice President and Head of Strategic Partnerships, Pfizer Ignite

    2023 - Current

    Pfizer Ignite is a new end-to-end offering for biotech partners that leverages Pfizer’s resources, scale and expertise to amplify and accelerate innovation from preclinical R&D through the development lifecycle. Learn more at www.pfizerignite.com.

1G

1910 Genetics

  • Independent Board Member

    2023

DICE Therapeutics

  • Board Member

    2020 - 2023

    Acquired by Eli Lilly (NYSE: LLY) August 2023, formerly NASDAQ: DICE

VN

Vigil Neuroscience

  • Board Member

    2020 - 2023

    NASDAQ: VIGL

KT

Kyverna Therapeutics

  • Board Member

    2022 - 2022

    NASDAQ: KYTX

TB

Transition Bio, Inc.

  • Board Member

    2022 - 2022

SI

StrideBio, Inc

  • Board Member

    2021 - 2022

CT

CAMP4 Therapeutics

  • Board Member

    2021 - 2022

MT

Mestag Therapeutics

  • Board Member

    2021 - 2022

GT

Garuda Therapeutics

  • Board Member

    2021 - 2022

Education

Investments

Kyverna Therapeutics

Series B

Total Funding: $170M

Opna Bio

Series A

Total Funding: $38M

CAMP4 Therapeutics

Series A

Total Funding: $180M

Transition Bio

Series A

Total Funding: $50M

Relevant Websites